Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer. Nanjo S, Wu W, Karachaliou N, Blakely CM, et al. J Clin Invest 2022 May 17. pii: 145099. doi: 10.1172/JCI145099.

Read + Share

Amedeo Smart

Independent Medical Education

Nanjo S, Wu W, Karachaliou N, Blakely CM, et al. Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer. J Clin Invest 2022 May 17. pii: 145099. doi: 10.1172/JCI145099.
PMID: 35579943